Lung Cancer

Lung Cancer Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Featured

The Future Role of Liquid Biopsies in Lung Cancer Detection

In the second installment of this roundtable discussion, experts sat down with Oncology Learning Network to discuss use of liquid biopsies to detect treatment resistance in lung cancer, areas for…

Durvalumab Shows Promise in Phase 2 Trial of Patients With Pleural Mesothelioma

Claire Verschraegen, MD, comments on a phase 2 study examining the use of chemotherapy with durvalumab in patients with pleural mesothelioma.

Joshua Bauml, MD, on Providing Lung Cancer Care During the COVID-19 Pandemic

Dr Bauml discusses how he and his lung cancer patients have adapted during this unprecedented time.

The Role of Antiangiogenics in NSCLC

Helen Ross, MD, discusses the role of antiangiogenics over time in treating NSCLC.

Pembrolizumab Plus Chemo Continues to Improve Outcomes in NSCLC

Shirish Gadgeel, MBBS, discusses updated findings from the KEYNOTE-189 clinical trial.

How I Practice Now: Treating Lung Cancer and Staying Well During COVID-19

Kristin Higgins, MD, Winship Cancer Institute, shares how the treatment of patients with lung cancer has been impacted by the COVID-19 pandemic.

Managing Oncogenic Driver Mutations in NSCLC

Helen Ross, MD, discusses the need to screen patients with NSCLC for driver mutations via NGS at diagnosis and after progression to help select first-, second-, and third-line targeted therapies.

How I Practice Now: Lung Cancer and the COVID-19 Climate

Joshua Bauml, MD, shares first-hand insight on the management of lung cancer during the COVID-19 pandemic.

The Future of Lung Cancer Screening

James L. Mulshine, MD, talks about what the future holds vis-a-vis advancements in lung cancer screening.